NCT03976375 · Interventional trial
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)
Overall registry status Completed
Phase 3
Conditions Metastatic Non-Small Cell Lung Cancer
Delaware Valley sites
- Fox Chase Cancer Center ( Site 1647) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory